丁酸钠
糖尿病肾病
化学
内分泌学
内科学
脂质积聚
激活剂(遗传学)
丁酸盐
肾
肾损伤
碱性磷酸酶
钠
磷酸酶
肾小球滤过
肾钠重吸收
肾小球硬化
肾脏疾病
肾肥大
糖尿病
肾病
脂质代谢
肾小管
脂滴
作者
Jiayin Tao,Sinan Ai,Yaoxian Wang,Yuning Liu,Jingwei Zhou,Qingqing Liu,Xu Wang,D. Li,Xin Li,Lin Wang,Jinyi Hou,Liang Peng,Zhen Wang
摘要
BACKGROUND AND PURPOSE: Extensive evidence indicates that lipid accumulation causes renal tubular injury, which further contributes to diabetic nephropathy (DN) progression. Short-chain fatty acids (SCFAs) play an important role in the maintenance of cellular metabolic health. Previous studies have found a significant deficiency of SCFAs in DN patients, although their effects on lipid accumulation in renal tubules have not been investigated. We have investigated the effect of sodium butyrate (NaB), one of the most abundant SCFAs, on renal tubular lipid accumulation in DN and elucidated its underlying protective mechanisms. EXPERIMENTAL APPROACH: The effects of NaB were investigated on renal tubular lipid accumulation in vitro (using a glucolipotoxicity-treated HK-2 cell line) and DN progression in vivo (with streptozotocin injection combined with a high-fat diet in C57BL/6J mice). RNA sequencing, surface plasmon resonance, pulldown MS assay, and molecular docking were applied to explore specific molecular mechanisms. KEY RESULTS: Our findings revealed that serum butyrate levels were reduced in DN patients and inversely correlated with DN severity. NaB supplementation improved renal tubular lipid accumulation and injury in HK-2 cells and DN mice. The protective effects of NaB were largely abrogated in kidney-specific Tfeb knockout mice. NaB directly interacted with PPP2R1A to promote the formation and activation of PP2A heterotrimers, thereby facilitating the dephosphorylation of TFEB and promoting lipophagy. CONCLUSIONS AND IMPLICATIONS: NaB functions as a PP2A-TFEB axis activator to restore lipophagy and ameliorate lipid accumulation in tubular epithelial cells, pointing to NaB as a promising protective agent against renal injury in DN patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI